HuL001

N/A

Report date: 2025/10/20 14:27:18

Base Information

Drug NameHuL001
Drug Alias NameHuL-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Alpha-enolase
TargetsAlpha-enolase
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHuniLife Biotechnology Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary FibrosisMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A